HK Stock MarketDetailed Quotes
02192 MEDLIVE
Watchlist
9.500
-0.280-2.86%
Market Closed 12/01 16:08 CST
9.900High9.200Low1.20MVolume
9.900Open9.780Pre Close11.48MTurnover0.17%Turnover Ratio33.69P/E (TTM)6.91BMarket Cap17.04952wk High52.49P/E (Static)727.06MShares5.47452wk Low1.38P/B6.91BFloat Cap46.788Historical High0.19Dividend TTM727.06MShs Float5.474Historical Low0.074Dividend LFY7.16%Amplitude2.01%Div YieldTTM9.538Avg Price500Lot Size0.78%Div Yield LFY
MEDLIVE Key Stats
All
YOY

(Q6)2023/06/30 | (FY)2022/12/31 | (Q6)2022/06/30 | (FY)2021/12/31 | (Q6)2021/06/30 | (FY)2020/12/31 | (Q6)2020/06/30 | (FY)2019/12/31 | (FY)2018/12/31 | |
---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Earning before tax | 202.92%102.66M | 93.11%135.04M | -7.08%33.89M | -33.31%69.93M | -12.36%36.47M | 183.39%104.85M | --41.62M | 130.95%37M | --16.02M |
Profit adjustment | |||||||||
Interest (income) - adjustment | -2,804.46%-71.01M | -1,123.72%-65.27M | ---2.45M | ---5.33M | ---- | ---- | ---- | ---- | ---- |
Investment loss (gain) | 4.43%-367K | -445.45%-720K | ---384K | 79.34%-132K | ---- | ---639K | ---151K | ---- | ---- |
Attributable subsidiary (profit) loss | ---3K | -700.00%-12K | ---- | --2K | ---- | ---- | ---- | ---- | ---- |
Impairment and provisions: | --0 | -145.40%-232K | --155K | 200.20%511K | --0 | -170.44%-510K | --211K | 236.74%724K | --215K |
-Impairment of trade receivables (reversal) | ---- | -145.40%-232K | --155K | 200.20%511K | ---- | -170.44%-510K | --211K | 236.74%724K | --215K |
Revaluation surplus: | --0 | 171.11%1.2M | --330K | --443K | --0 | --0 | --0 | --0 | --0 |
-Other fair value changes | ---- | 171.11%1.2M | --330K | --443K | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | --0 | 5.81%91K | -87.50%8K | --86K | --64K | --0 | --0 | --0 | --0 |
-Loss (gain) on sale of property, machinery and equipment | ---- | 5.81%91K | -87.50%8K | --86K | --64K | ---- | ---- | ---- | ---- |
Depreciation and amortization: | 5.23%4.32M | 46.15%8.99M | 47.35%4.11M | 15.67%6.15M | 5.49%2.79M | 10.02%5.32M | --2.64M | 10.95%4.83M | --4.36M |
-Depreciation | -4.72%3.39M | 27.88%7.56M | 27.76%3.56M | 11.19%5.91M | 5.49%2.79M | 10.02%5.32M | --2.64M | 10.95%4.83M | --4.36M |
-Amortization of intangible assets | 70.15%929K | 500.00%1.43M | --546K | --238K | ---- | ---- | ---- | ---- | ---- |
Financial expense | -30.85%195K | -0.75%531K | 22.08%282K | 155.98%535K | 117.92%231K | -29.39%209K | --106K | -32.57%296K | --439K |
Special items | -40.01%6.38M | 15.57%16.48M | 111.86%10.63M | 1,871.06%14.26M | 1,885.41%5.02M | ---805K | ---281K | ---- | ---- |
Operating profit before the change of operating capital | -9.45%42.17M | 11.16%96.09M | 4.49%46.57M | -20.27%86.44M | 0.96%44.57M | 153.02%108.42M | --44.15M | 103.77%42.85M | --21.03M |
Change of operating capital | |||||||||
Inventory (increase) decrease | 91.45%-10K | -11.70%-105K | ---117K | ---94K | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | -22.10%7M | 39.76%-17.13M | 315.27%8.98M | -349.39%-28.43M | -179.26%-4.17M | 38.83%-6.33M | --5.26M | -336.74%-10.34M | --4.37M |
Accounts payable increase (decrease) | 191.18%8.83M | 172.67%16.87M | -160.84%-9.68M | -62.37%6.19M | 124.79%15.91M | 83.91%16.44M | --7.08M | 67.96%8.94M | --5.32M |
prepayments (increase)decrease | -978.55%-5.94M | 42.29%-1.29M | 1,329.09%676K | -1,221.61%-2.23M | -106.42%-55K | 146.71%199K | --857K | -3.65%-426K | ---411K |
Cash from business operations | 17.26%39.8M | 47.65%86.51M | -28.47%33.94M | -53.59%58.59M | -8.58%47.44M | 337.30%126.25M | --51.9M | 21.49%28.87M | --23.77M |
Other taxs | -76.43%-9.48M | 34.15%-9.33M | 50.00%-5.37M | 6.87%-14.16M | -124.90%-10.74M | -2,176.05%-15.2M | ---4.78M | 60.10%-668K | ---1.67M |
Special items of business | 1.94%-12.25M | -141.63%-7.92M | -41.75%-12.5M | -143.60%-3.28M | -61.77%-8.82M | 161.91%7.52M | ---5.45M | -85.65%-12.15M | ---6.54M |
Net cash from operations | 6.14%30.32M | 73.72%77.19M | -22.17%28.57M | -59.99%44.43M | -22.11%36.7M | 293.75%111.05M | --47.12M | 27.67%28.2M | --22.09M |
Cash flow from investment activities | |||||||||
Interest received - investment | 2,741.92%69.49M | 899.15%43.51M | --2.45M | --4.36M | ---- | ---- | ---- | ---- | ---- |
Decrease in deposits (increase) | ---3.98B | ---3.58B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | 67.80%-390K | 31.61%-1.35M | -41.64%-1.21M | -214.38%-1.97M | -101.18%-855K | 74.20%-626K | ---425K | 21.77%-2.43M | ---3.1M |
Purchase of intangible assets | -153.19%-5.95M | ---6.14M | ---2.35M | ---- | ---- | ---- | ---- | ---- | ---- |
Acquisition of subsidiaries | 5.33%-40.33M | 19.55%-42.6M | ---42.6M | ---52.95M | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | 360.16%1.77M | -86.35%720K | --384K | -96.02%5.28M | ---- | --132.64M | ---- | ---- | ---- |
Cash on investment | ---5M | ---- | ---- | 96.02%-5.25M | ---- | ---132M | ---40M | ---- | ---- |
Net cash from investment operations | -9,028.75%-3.96B | -6,994.35%-3.59B | -4,968.42%-43.34M | -388,876.92%-50.54M | 97.88%-855K | 100.54%13K | ---40.43M | 21.77%-2.43M | ---3.1M |
Net cash before financing | -26,480.17%-3.93B | -57,338.87%-3.51B | -141.20%-14.77M | -105.50%-6.11M | 435.28%35.85M | 330.85%111.06M | --6.7M | 35.74%25.78M | --18.99M |
Cash flow from financing activities | |||||||||
New borrowing | ---- | ---- | ---- | ---- | --6.46M | ---- | ---- | ---- | ---- |
Refund | ---- | ---- | ---- | --6.45M | ---- | ---- | ---- | ---- | ---2.35M |
Issuing shares | ---- | -100.00%1K | ---- | --4.03B | ---- | ---- | ---- | ---- | ---- |
Interest paid - financing | 30.85%-195K | 0.75%-531K | -22.08%-282K | -155.98%-535K | -117.92%-231K | 29.39%-209K | ---106K | 32.57%-296K | ---439K |
Dividends paid - financing | -65.84%-7.8M | 81.70%-16.84M | ---4.7M | ---92M | ---- | ---- | ---- | ---- | ---- |
Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---144.8M | ---5.35M | ---- | ---- | ---- | ---- |
Other items of the financing business | 1.41%-2.73M | 50.93%-5.01M | -105.04%-2.77M | -289.14%-10.22M | -13.54%-1.35M | 16.19%-2.63M | ---1.19M | -2.45%-3.13M | ---3.06M |
Net cash from financing operations | -38.32%-10.73M | -100.59%-22.38M | -1,539.32%-7.75M | 133,905.58%3.79B | 63.47%-473K | 17.33%-2.83M | ---1.3M | 41.36%-3.43M | ---5.85M |
Effect of rate | -23.46%146.84M | 711.66%329.89M | 710,411.11%191.84M | -359,453.33%-53.93M | 575.00%27K | -475.00%-15K | --4K | -71.43%4K | --14K |
Net Cash | -17,377.02%-3.94B | -193.26%-3.53B | -163.67%-22.52M | 3,398.15%3.79B | 554.85%35.38M | 384.26%108.23M | --5.4M | 70.03%22.35M | --13.14M |
Begining period cash | 7.94%4.19B | 2,537.14%3.88B | 2,537.14%3.88B | 278.30%147.1M | 278.30%147.1M | 135.23%38.88M | --38.88M | 390.21%16.53M | --3.37M |
Cash at the end | -90.18%397.75M | -82.52%678.25M | 2,118.35%4.05B | 2,537.14%3.88B | 312.06%182.5M | 278.30%147.1M | --44.29M | 135.23%38.88M | --16.53M |
Cash balance analysis | |||||||||
Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--